Christian Antoine Lucien Ribeyrolle - 01 Mar 2023 Form 4 Insider Report for RAYONIER ADVANCED MATERIALS INC. (RYAM)

Role: Vice President, Biomaterials
Signature: Brenda K. Davis, Attorney-in-Fact
Issuer symbol: RYAM
Transactions as of: 01 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2023, 16:02:09 UTC
Previous filing: 03 Mar 2022
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RYAM	Common Stock	Award	$0	+4,805	+122%	$0.000000	8,730	01 Mar 2023	Direct	F1
transaction	RYAM	Common Stock	Options Exercise	$0	+3,334	+38%	$0.000000	12,064	01 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RYAM	Restricted Stock Units	Award	$0	+8,940		$0.000000	8,940	01 Mar 2023	Common Stock	8,940		Direct	F2
transaction	RYAM	Restricted Stock Units	Options Exercise	$0	-3,334	-100%	$0.000000^*	0	01 Mar 2023	Common Stock	3,334		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Paid pursuant to 2020 Performance Share Unit Award Agreement.
F2	Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.
F3	Due to an administrative error the exercisable date and the expiration date were incorrectly reported as March 2, 2023 instead of March 1, 2023.